bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Table 2 from A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Authors: Sarker Debashis , Dawson Nancy A. , Aparicio Ana M. , Dorff Tanya B. , Pantuck Allan J. , Vaishampayan Ulka N. , Henson Lynn , Vasist Lakshmi , Roy-Ghanta Sumita , Gorczyca Michele , York Whitney , Ganji Gopinath , Tolson Jerry , de Bono Johann S.
Published: April 2023

Supplementary Table 2. Summary of serious adverse events.
Supplementary Table 1 from A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Authors: Sarker Debashis , Dawson Nancy A. , Aparicio Ana M. , Dorff Tanya B. , Pantuck Allan J. , Vaishampayan Ulka N. , Henson Lynn , Vasist Lakshmi , Roy-Ghanta Sumita , Gorczyca Michele , York Whitney , Ganji Gopinath , Tolson Jerry , de Bono Johann S.
Published: April 2023

Supplementary Table 1. PCWG2 criteria for progression.
Supplementary Methods from A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Authors: Sarker Debashis , Dawson Nancy A. , Aparicio Ana M. , Dorff Tanya B. , Pantuck Allan J. , Vaishampayan Ulka N. , Henson Lynn , Vasist Lakshmi , Roy-Ghanta Sumita , Gorczyca Michele , York Whitney , Ganji Gopinath , Tolson Jerry , de Bono Johann S.
Published: April 2023

Supplementary methods: PTEN screening
Supplementary Table 1 from Standardized Uptake Value for 18F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer
Authors: Floberg John M. , Zhang Jin , Muhammad Naoshad , DeWees Todd A. , Inkman Matthew , Chen Kevin , Lin Alexander J. , Rashmi Ramachandran , Jayachandran Kay , Edelson Brian T. , Siegel Barry A. , Dehdashti Farrokh , Grigsby Perry W. , Markovina Stephanie , Schwarz Julie K.
Published: April 2023

Bootstrap multivariate analysis results.
Supplementary Figure 2 from A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Authors: Sarker Debashis , Dawson Nancy A. , Aparicio Ana M. , Dorff Tanya B. , Pantuck Allan J. , Vaishampayan Ulka N. , Henson Lynn , Vasist Lakshmi , Roy-Ghanta Sumita , Gorczyca Michele , York Whitney , Ganji Gopinath , Tolson Jerry , de Bono Johann S.
Published: April 2023

Dashed lines represent 95% confidence intervals. PCWG2, Prostate Cancer Working Group 2; PSA, prostate-specific antigen.
Supplementary Figure 2S from Standardized Uptake Value for 18F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer
Authors: Floberg John M. , Zhang Jin , Muhammad Naoshad , DeWees Todd A. , Inkman Matthew , Chen Kevin , Lin Alexander J. , Rashmi Ramachandran , Jayachandran Kay , Edelson Brian T. , Siegel Barry A. , Dehdashti Farrokh , Grigsby Perry W. , Markovina Stephanie , Schwarz Julie K.
Published: April 2023

Representative image of an auto-contoured metabolic tumor volume on simulation CT scan fused with a diagnostic PET scan.
Supplementary Figure from Targeting a Radiosensitizing Antibody–Drug Conjugate to a Radiation-Inducible Antigen
Authors: Lewis Calvin D. , Singh Abhay K. , Hsu Fong-Fu , Thotala Dinesh , Hallahan Dennis E. , Kapoor Vaishali
Published: April 2023

Supplementary Figure from Targeting a Radiosensitizing Antibody–Drug Conjugate to a Radiation-Inducible Antigen
Figure S1 from Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer
Authors: Vathiotis Ioannis A. , Moutafi Myrto K. , Divakar Prajan , Aung Thazin Nwe , Qing Tao , Fernandez Aileen , Yaghoobi Vesal , El-Abed Sarra , Wang Yingbo , Guillaume Sebastien , Nuciforo Paolo , Huober Jens , Di Cosimo Serena , Kim Sung-Bae , Harbeck Nadia , Gomez Henry , Shafi Saba , Syrigos Konstantinos N. , Fountzilas George , Sotiriou Christos , Pusztai Lajos , Warren Sarah , Rimm David L.
Published: April 2023

Signal to background ratio across different areas of interest for all targets
Figure S2 from Phase I–II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAFV600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism
Authors: Louveau Baptiste , Resche-Rigon Matthieu , Lesimple Thierry , Da Meda Laetitia , Pracht Marc , Baroudjian Barouyr , Delyon Julie , Amini-Adle Mona , Dutriaux Caroline , Reger de Moura Coralie , Sadoux Aurélie , Jouenne Fanélie , Ghrieb Zineb , Vilquin Paul , Bouton Didier , Tibi Annick , Huguet Samuel , Rezai Keyvan , Battistella Maxime , Mourah Samia , Lebbe Céleste
Published: April 2023

Figure S2. (A) Change in the tumor burden from baseline over time according to RECIST for all the included patients. The tumor burden was measured as the sum of the longest diameters of target lesions. Each line represents a patient. (B) Kaplan-Meier plot of the overall survival for all the included patients (N =18). (C) Kaplan-Meier plot of the progression-free survival for all the included patients (N =18).
Supplementary Data from Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial–Mesenchymal Transition in Recurrent Bladder Cancer
Authors: Wang Huanjun , Mei Yan , Luo Cheng , Huang Qun , Wang Zifeng , Lu Guan-Ming , Qin Lili , Sun Zhun , Huang Chao-Wen , Yang Zhi-Wen , Chen Junxing , Yin Weiguo , Qian Chao-Nan , Zeng Jianming , Chen Lingwu , Leng Qibin , Guo Yan , Jia Guangshuai
Published: April 2023

Supplementary Data from Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial–Mesenchymal Transition in Recurrent Bladder Cancer
Supplementary Figure 6 from Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies
Authors: Lee Jaewon J. , Bernard Vincent , Semaan Alexander , Monberg Maria E. , Huang Jonathan , Stephens Bret M. , Lin Daniel , Rajapakshe Kimal I. , Weston Brian R. , Bhutani Manoop S. , Haymaker Cara L. , Bernatchez Chantale , Taniguchi Cullen M. , Maitra Anirban , Guerrero Paola A.
Published: April 2023

Figure
Supplementary Table S2 from Clinical Proteomics of Metastatic Melanoma Reveals Profiles of Organ Specificity and Treatment Resistance
Authors: Beck Lir , Harel Michal , Yu Shun , Markovits Ettai , Boursi Ben , Markel Gal , Geiger Tamar
Published: April 2023

Supplementary Table S2
Supplemental Figure 4 from Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes
Authors: Chang Jason C. , Offin Michael , Falcon Christina , Brown David , Houck-Loomis Brian R. , Meng Fanli , Rudneva Vasilisa A. , Won Helen H. , Amir Sharon , Montecalvo Joseph , Desmeules Patrice , Kadota Kyuichi , Adusumilli Prasad S. , Rusch Valerie W. , Teed Sarah , Sabari Joshua K. , Benayed Ryma , Nafa Khedoudja , Borsu Laetitia , Li Bob T. , Schram Alison M. , Arcila Maria E. , Travis William D. , Ladanyi Marc , Drilon Alexander , Rekhtman Natasha
Published: April 2023

Supplemental Figure 4. Comparison of overall and recurrence-free survival in CDKN2A-wild type and CDKN2A-mutant IMAs.
Supplementary Data from Phase I Study of MK-4166, an Anti-human Glucocorticoid-Induced TNF Receptor Antibody, Alone or with Pembrolizumab in Advanced Solid Tumors
Authors: Papadopoulos Kyriakos P. , Autio Karen , Golan Talia , Dobrenkov Konstantin , Chartash Elliot , Chen Qiusheng , Wnek Richard , Long Georgina V.
Published: April 2023

Supplementary Material
Table S8 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
Authors: Monaco Kelli-Ann , Delach Scott , Yuan Jing , Mishina Yuji , Fordjour Paul , Labrot Emma , McKay Daniel , Guo Ribo , Higgins Stacy , Wang Hui Qin , Liang Jinsheng , Bui Karen , Green John , Aspesi Peter , Ambrose Jessi , Mapa Felipa , Griner Lesley , Jaskelioff Mariela , Fuller John , Crawford Kenneth , Pardee Gwynn , Widger Stephania , Hammerman Peter S. , Engelman Jeffrey A. , Stuart Darrin D. , Cooke Vesselina G. , Caponigro Giordano
Published: April 2023

Growth inhibition IC50 values (nM) of several RAF inhibitors in a panel of cell lines
Supplementary Data from Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer
Authors: Kazi Aslamuzzaman , Chen Liwei , Xiang Shengyan , Vangipurapu Rajanikanth , Yang Hua , Beato Francisca , Fang Bin , Williams Terence M. , Husain Kazim , Underwood Patrick , Fleming Jason B. , Malafa Mokenge , Welsh Eric A. , Koomen John , Trevino José , Sebti Saïd M.
Published: April 2023

Supplementary Methods
Supplementary Data from Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer
Authors: Kazi Aslamuzzaman , Chen Liwei , Xiang Shengyan , Vangipurapu Rajanikanth , Yang Hua , Beato Francisca , Fang Bin , Williams Terence M. , Husain Kazim , Underwood Patrick , Fleming Jason B. , Malafa Mokenge , Welsh Eric A. , Koomen John , Trevino José , Sebti Saïd M.
Published: April 2023

Supplementary Table 2
Figure S4 from Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors
Authors: Do Khanh T. , Kochupurakkal Bose , Kelland Sarah , de Jonge Adrienne , Hedglin Jennifer , Powers Allison , Quinn Nicholas , Gannon Courtney , Vuong Loan , Parmar Kalindi , Lazaro Jean-Bernard , D'Andrea Alan D. , Shapiro Geoffrey I.
Published: April 2023

Immunohistochemical Profile Patient 21
Supplementary tables from Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas
Authors: Mudianto Tenny , Campbell Katie M. , Webb Jason , Zolkind Paul , Skidmore Zachary L. , Riley Rachel , Barnell Erica K. , Ozgenc Ibrahim , Giri Tusar , Dunn Gavin P. , Adkins Douglas R. , Griffith Malachi , Egloff Ann Marie , Griffith Obi L. , Uppaluri Ravindra
Published: April 2023

Supplementary Tables
Supplementary Figure 3 from Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas
Authors: Mudianto Tenny , Campbell Katie M. , Webb Jason , Zolkind Paul , Skidmore Zachary L. , Riley Rachel , Barnell Erica K. , Ozgenc Ibrahim , Giri Tusar , Dunn Gavin P. , Adkins Douglas R. , Griffith Malachi , Egloff Ann Marie , Griffith Obi L. , Uppaluri Ravindra
Published: April 2023

Supplementary Figure 3
Supplementary Figure 2 from Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas
Authors: Mudianto Tenny , Campbell Katie M. , Webb Jason , Zolkind Paul , Skidmore Zachary L. , Riley Rachel , Barnell Erica K. , Ozgenc Ibrahim , Giri Tusar , Dunn Gavin P. , Adkins Douglas R. , Griffith Malachi , Egloff Ann Marie , Griffith Obi L. , Uppaluri Ravindra
Published: April 2023

Supplementary Figure 2
Supplementary Table 2 from The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model
Authors: Gordon Max J. , Kaempf Andy , Sitlinger Andrea , Shouse Geoffrey , Mei Matthew , Brander Danielle M. , Salous Tareq , Hill Brian T. , Alqahtani Hamood , Choi Michael , Churnetski Michael C. , Cohen Jonathon B. , Stephens Deborah M. , Siddiqi Tanya , Rivera Xavier , Persky Daniel , Wisniewski Paul , Patel Krish , Shadman Mazyar , Park Byung , Danilov Alexey V.
Published: April 2023

S Table 2
Supplementary Fig 1 from The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model
Authors: Gordon Max J. , Kaempf Andy , Sitlinger Andrea , Shouse Geoffrey , Mei Matthew , Brander Danielle M. , Salous Tareq , Hill Brian T. , Alqahtani Hamood , Choi Michael , Churnetski Michael C. , Cohen Jonathon B. , Stephens Deborah M. , Siddiqi Tanya , Rivera Xavier , Persky Daniel , Wisniewski Paul , Patel Krish , Shadman Mazyar , Park Byung , Danilov Alexey V.
Published: April 2023

Supplemental Figure 1. CIRS correlates with outcomes in CLL (derivation dataset).
Figure S5 from Regulation of OATP1B1 Function by Tyrosine Kinase–mediated Phosphorylation
Authors: Hayden Elizabeth R. , Chen Mingqing , Pasquariello Kyle Z. , Gibson Alice A. , Petti James J. , Shen Shichen , Qu Jun , Ong Su Sien , Chen Taosheng , Jin Yan , Uddin Muhammad Erfan , Huang Kevin M. , Paz Aviv , Sparreboom Alex , Hu Shuiying , Sprowl Jason A.
Published: April 2023

Assessment of lapatinib or trametinib as OATP1B1 substrates. (A) Percent uptake of 3H-lapatinib (1 µM) in OATP1B1 overexpressing HEK293 cells relative to uptake in HEK293 cells transfected with a vector control (VC) (n=3, from a single experiment). (B) Lineweaver-Burke plot for OATP1B1-dependent uptake in HEK293-OATP1B1 cells treated with various concentrations of trametinib (0 - 5 µM) and 8FcA (0 - 40 µM) (n=9, and a combination of 3 independent experiments) . * denotes P < 0.001 vs VC. All values represent mean {plus minus} SEM.
Figure S3 from Regulation of OATP1B1 Function by Tyrosine Kinase–mediated Phosphorylation
Authors: Hayden Elizabeth R. , Chen Mingqing , Pasquariello Kyle Z. , Gibson Alice A. , Petti James J. , Shen Shichen , Qu Jun , Ong Su Sien , Chen Taosheng , Jin Yan , Uddin Muhammad Erfan , Huang Kevin M. , Paz Aviv , Sparreboom Alex , Hu Shuiying , Sprowl Jason A.
Published: April 2023

A structural model of OATP1B1. The model was generated by Phyre2 and presented as a cartoon. Y640 and Y645 are highlighted in blue and the image was produced with PyMOL.
Supplementary Data Legends from Spatial Mapping and Immunomodulatory Role of the OX40/OX40L Pathway in Human Non–Small Cell Lung Cancer
Authors: Porciuncula Angelo , Morgado Micaela , Gupta Richa , Syrigos Kostas , Meehan Robert , Zacharek Sima J. , Frederick Joshua P. , Schalper Kurt A.
Published: April 2023

Supplementary Data Legends
Figure S4 from Spatial Mapping and Immunomodulatory Role of the OX40/OX40L Pathway in Human Non–Small Cell Lung Cancer
Authors: Porciuncula Angelo , Morgado Micaela , Gupta Richa , Syrigos Kostas , Meehan Robert , Zacharek Sima J. , Frederick Joshua P. , Schalper Kurt A.
Published: April 2023

Supplementary Figure S4
Figure S3 from Spatial Mapping and Immunomodulatory Role of the OX40/OX40L Pathway in Human Non–Small Cell Lung Cancer
Authors: Porciuncula Angelo , Morgado Micaela , Gupta Richa , Syrigos Kostas , Meehan Robert , Zacharek Sima J. , Frederick Joshua P. , Schalper Kurt A.
Published: April 2023

Supplementary Figure S3
Figure S2 from Spatial Mapping and Immunomodulatory Role of the OX40/OX40L Pathway in Human Non–Small Cell Lung Cancer
Authors: Porciuncula Angelo , Morgado Micaela , Gupta Richa , Syrigos Kostas , Meehan Robert , Zacharek Sima J. , Frederick Joshua P. , Schalper Kurt A.
Published: April 2023

Supplementary Figure S2
Figure S1 from Spatial Mapping and Immunomodulatory Role of the OX40/OX40L Pathway in Human Non–Small Cell Lung Cancer
Authors: Porciuncula Angelo , Morgado Micaela , Gupta Richa , Syrigos Kostas , Meehan Robert , Zacharek Sima J. , Frederick Joshua P. , Schalper Kurt A.
Published: April 2023

Supplementary Figure S1
Table S4 from Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors
Authors: Thompson Patricia A. , Huang Chuan , Yang Jie , Wertheim Betsy C. , Roe Denise , Zhang Xiaoyue , Ding Jie , Chalasani Pavani , Preece Christina , Martinez Jessica , Chow H.-H. Sherry , Stopeck Alison T.
Published: April 2023

Table summarizing the most common toxicities.
Table S3 from Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors
Authors: Thompson Patricia A. , Huang Chuan , Yang Jie , Wertheim Betsy C. , Roe Denise , Zhang Xiaoyue , Ding Jie , Chalasani Pavani , Preece Christina , Martinez Jessica , Chow H.-H. Sherry , Stopeck Alison T.
Published: April 2023

Table showing within subject variability in collagen fiber features.
Supplementary Figure 2 from Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Authors: Hajda Jacek , Leuchs Barbara , Angelova Assia L. , Frehtman Veronika , Rommelaere Jean , Mertens Mieke , Pilz Maximilian , Kieser Meinhard , Krebs Ottheinz , Dahm Michael , Huber Bernard , Engeland Christine E. , Mavratzas Athanasios , Hohmann Nicolas , Schreiber Jutta , Jäger Dirk , Halama Niels , Sedlaczek Oliver , Gaida Matthias M. , Daniel Volker , Springfeld Christoph , Ungerechts Guy
Published: April 2023

Serum CA19-9 levels
Supplementary Figure 1 from Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Authors: Hajda Jacek , Leuchs Barbara , Angelova Assia L. , Frehtman Veronika , Rommelaere Jean , Mertens Mieke , Pilz Maximilian , Kieser Meinhard , Krebs Ottheinz , Dahm Michael , Huber Bernard , Engeland Christine E. , Mavratzas Athanasios , Hohmann Nicolas , Schreiber Jutta , Jäger Dirk , Halama Niels , Sedlaczek Oliver , Gaida Matthias M. , Daniel Volker , Springfeld Christoph , Ungerechts Guy
Published: April 2023

Overall Survival & Progression Free Survival
Figure S2 from Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors
Authors: Thompson Patricia A. , Huang Chuan , Yang Jie , Wertheim Betsy C. , Roe Denise , Zhang Xiaoyue , Ding Jie , Chalasani Pavani , Preece Christina , Martinez Jessica , Chow H.-H. Sherry , Stopeck Alison T.
Published: April 2023

Magnetic Resonance Percent Breast Density by Study Group at Baseline.
Figure S1 from Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors
Authors: Thompson Patricia A. , Huang Chuan , Yang Jie , Wertheim Betsy C. , Roe Denise , Zhang Xiaoyue , Ding Jie , Chalasani Pavani , Preece Christina , Martinez Jessica , Chow H.-H. Sherry , Stopeck Alison T.
Published: April 2023

Relationship between baseline percent breast density by MRI and descriptive breast density by mammogram in the study population.
Supplementary Figures from Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Authors: Parikh Aparna R. , Van Seventer Emily E. , Siravegna Giulia , Hartwig Anna V. , Jaimovich Ariel , He Yupeng , Kanter Katie , Fish Madeleine G. , Fosbenner Kathryn D. , Miao Benchun , Phillips Susannah , Carmichael John H. , Sharma Nihaarika , Jarnagin Joy , Baiev Islam , Shah Yojan S. , Fetter Isobel J. , Shahzade Heather A. , Allen Jill N. , Blaszkowsky Lawrence S. , Clark Jeffrey W. , Dubois Jon S. , Franses Joseph W. , Giantonio Bruce J. , Goyal Lipika , Klempner Samuel J. , Nipp Ryan D. , Roeland Eric J. , Ryan David P. , Weekes Colin D. , Wo Jennifer Y. , Hong Theodore S. , Bordeianou Liliana , Ferrone Cristina R. , Qadan Motaz , Kunitake Hiroko , Berger David , Ricciardi Rocco , Cusack James C. , Raymond Victoria M. , Talasaz AmirAli , Boland Genevieve M. , Corcoran Ryan B.
Published: April 2023

Supplementary Figures
Supplementary Data from ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel Adenocarcinoma
Authors: Pedersen Katrina S. , Foster Nathan R. , Overman Michael J. , Boland Patrick M. , Kim Sunnie S. , Arrambide Kathryn A. , Jaszewski Brandy L. , Bekaii-Saab Tanios , Graham Rondell P. , Welch Jack , Wilson Richard H. , McWilliams Robert R.
Published: April 2023

Revised supplemental figures and tables
Figure S8. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
Authors: de Clercq Nicolien C. , van den Ende Tom , Prodan Andrei , Hemke Robert , Davids Mark , Pedersen Helle K. , Nielsen Henrik B. , Groen A.K. , de Vos Willem M. , van Laarhoven Hanneke W.M. , Nieuwdorp Max
Published: April 2023

Top 15 microbes week 4
Figure S6. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
Authors: de Clercq Nicolien C. , van den Ende Tom , Prodan Andrei , Hemke Robert , Davids Mark , Pedersen Helle K. , Nielsen Henrik B. , Groen A.K. , de Vos Willem M. , van Laarhoven Hanneke W.M. , Nieuwdorp Max
Published: April 2023

Microbial genera plots
Figure S3. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
Authors: de Clercq Nicolien C. , van den Ende Tom , Prodan Andrei , Hemke Robert , Davids Mark , Pedersen Helle K. , Nielsen Henrik B. , Groen A.K. , de Vos Willem M. , van Laarhoven Hanneke W.M. , Nieuwdorp Max
Published: April 2023

Donor engraftment of species.
Figure S2. from Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study
Authors: de Clercq Nicolien C. , van den Ende Tom , Prodan Andrei , Hemke Robert , Davids Mark , Pedersen Helle K. , Nielsen Henrik B. , Groen A.K. , de Vos Willem M. , van Laarhoven Hanneke W.M. , Nieuwdorp Max
Published: April 2023

Per protocol analyses: DCR, PFS and OS.
SFigure5 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Authors: Steele Nina G. , Biffi Giulia , Kemp Samantha B. , Zhang Yaqing , Drouillard Donovan , Syu LiJyun , Hao Yuan , Oni Tobiloba E. , Brosnan Erin , Elyada Ela , Doshi Abhishek , Hansma Christa , Espinoza Carlos , Abbas Ahmed , The Stephanie , Irizarry-Negron Valerie , Halbrook Christopher J. , Franks Nicole E. , Hoffman Megan T. , Brown Kristee , Carpenter Eileen S. , Nwosu Zeribe C. , Johnson Craig , Lima Fatima , Anderson Michelle A. , Park Youngkyu , Crawford Howard C. , Lyssiotis Costas A. , Frankel Timothy L. , Rao Arvind , Bednar Filip , Dlugosz Andrzej A. , Preall Jonathan B. , Tuveson David A. , Allen Benjamin L. , Pasca di Magliano Marina
Published: April 2023

SFigure5
SFigure4 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Authors: Steele Nina G. , Biffi Giulia , Kemp Samantha B. , Zhang Yaqing , Drouillard Donovan , Syu LiJyun , Hao Yuan , Oni Tobiloba E. , Brosnan Erin , Elyada Ela , Doshi Abhishek , Hansma Christa , Espinoza Carlos , Abbas Ahmed , The Stephanie , Irizarry-Negron Valerie , Halbrook Christopher J. , Franks Nicole E. , Hoffman Megan T. , Brown Kristee , Carpenter Eileen S. , Nwosu Zeribe C. , Johnson Craig , Lima Fatima , Anderson Michelle A. , Park Youngkyu , Crawford Howard C. , Lyssiotis Costas A. , Frankel Timothy L. , Rao Arvind , Bednar Filip , Dlugosz Andrzej A. , Preall Jonathan B. , Tuveson David A. , Allen Benjamin L. , Pasca di Magliano Marina
Published: April 2023

SFigure4
SFigure3 from Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Authors: Steele Nina G. , Biffi Giulia , Kemp Samantha B. , Zhang Yaqing , Drouillard Donovan , Syu LiJyun , Hao Yuan , Oni Tobiloba E. , Brosnan Erin , Elyada Ela , Doshi Abhishek , Hansma Christa , Espinoza Carlos , Abbas Ahmed , The Stephanie , Irizarry-Negron Valerie , Halbrook Christopher J. , Franks Nicole E. , Hoffman Megan T. , Brown Kristee , Carpenter Eileen S. , Nwosu Zeribe C. , Johnson Craig , Lima Fatima , Anderson Michelle A. , Park Youngkyu , Crawford Howard C. , Lyssiotis Costas A. , Frankel Timothy L. , Rao Arvind , Bednar Filip , Dlugosz Andrzej A. , Preall Jonathan B. , Tuveson David A. , Allen Benjamin L. , Pasca di Magliano Marina
Published: April 2023

SFigure3
Table.S8 from Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma
Authors: Lone Waseem , Bouska Alyssa , Sharma Sunandini , Amador Catalina , Saumyaranjan Mallick , Herek Tyler A. , Heavican Tayla B. , Yu Jiayu , Lim Soon Thye , Ong Choon Kiat , Slack Graham W. , Savage Kerry J. , Rosenwald Andreas , Ott German , Cook James R. , Feldman Andrew L. , Rimsza Lisa M. , McKeithan Timothy W. , Greiner Timothy C. , Weisenburger Dennis D. , Melle Federica , Motta Giovanna , Pileri Stefano , Vose Julie M. , Chan Wing C. , Iqbal Javeed
Published: April 2023

Table S8. Unique miRNA signatures in PTCL entities
Supplementary Material from Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab ± Ipilimumab in Gastric Cancer/Gastroesophageal Junction Cancer
Authors: Lei Ming , Siemers Nathan O. , Pandya Dimple , Chang Han , Sanchez Teresa , Harbison Christopher , Szabo Peter M. , Janjigian Yelena , Ott Patrick A. , Sharma Padmanee , Bendell Johanna , Evans Thomas R. Jeffry , de Braud Filippo , Chau Ian , Boyd Zachary
Published: April 2023

Supplementary Material
Table.S6 from Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma
Authors: Lone Waseem , Bouska Alyssa , Sharma Sunandini , Amador Catalina , Saumyaranjan Mallick , Herek Tyler A. , Heavican Tayla B. , Yu Jiayu , Lim Soon Thye , Ong Choon Kiat , Slack Graham W. , Savage Kerry J. , Rosenwald Andreas , Ott German , Cook James R. , Feldman Andrew L. , Rimsza Lisa M. , McKeithan Timothy W. , Greiner Timothy C. , Weisenburger Dennis D. , Melle Federica , Motta Giovanna , Pileri Stefano , Vose Julie M. , Chan Wing C. , Iqbal Javeed
Published: April 2023

Table S6.Differentially expressed miRNA between naïve CD4+T-cells and different Polarized TH subsets (Red=Upregulated); (Black=Downregulated)
Supplementary Tables from The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
Authors: Arai Hiroyuki , Elliott Andrew , Xiu Joanne , Wang Jingyuan , Battaglin Francesca , Kawanishi Natsuko , Soni Shivani , Zhang Wu , Millstein Joshua , Sohal Davendra , Goldberg Richard M. , Hall Michael J. , Scott Aaron J. , Khushman Moh'd , Hwang Jimmy J. , Lou Emil , Weinberg Benjamin A. , Marshall John L. , Lockhart Albert C. , Stafford Phillip , Zhang Jian , Moretto Roberto , Cremolini Chiara , Korn W. Michael , Lenz Heinz-Josef
Published: April 2023

Table S1-S12
Supplementary Methods from The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
Authors: Arai Hiroyuki , Elliott Andrew , Xiu Joanne , Wang Jingyuan , Battaglin Francesca , Kawanishi Natsuko , Soni Shivani , Zhang Wu , Millstein Joshua , Sohal Davendra , Goldberg Richard M. , Hall Michael J. , Scott Aaron J. , Khushman Moh'd , Hwang Jimmy J. , Lou Emil , Weinberg Benjamin A. , Marshall John L. , Lockhart Albert C. , Stafford Phillip , Zhang Jian , Moretto Roberto , Cremolini Chiara , Korn W. Michael , Lenz Heinz-Josef
Published: April 2023

Details of NGS, WTS, CMS, and MSI/MMR status
Figure.S7 from Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma
Authors: Lone Waseem , Bouska Alyssa , Sharma Sunandini , Amador Catalina , Saumyaranjan Mallick , Herek Tyler A. , Heavican Tayla B. , Yu Jiayu , Lim Soon Thye , Ong Choon Kiat , Slack Graham W. , Savage Kerry J. , Rosenwald Andreas , Ott German , Cook James R. , Feldman Andrew L. , Rimsza Lisa M. , McKeithan Timothy W. , Greiner Timothy C. , Weisenburger Dennis D. , Melle Federica , Motta Giovanna , Pileri Stefano , Vose Julie M. , Chan Wing C. , Iqbal Javeed
Published: April 2023

Figure S7: Functional Validation of miR-126 and miR-145: A. Western blot of the miR-126 target S1PR2 in CD4+ T cells and Hut78 T cells transduced with empty vector or miR-126. B. Relative mRNA expression of S1PR2, BCL6, and PRDM1 in CD4+ T cells transduced with miR-126 compared to cells transduced with vector control. C. Flow cytometry histogram of CXCR5 expression in the Raji and DHL16 B-cell lines.D Flow cytometry assessment of the number of migrated CD4+ Jurkat cells expressing empty vector or miR-126, with S1PR2 inhibitor (JTE-013) E. Western blot of S1PR2 and RhoA-GTP in Jurkat cells transduced with empty vector or miR-126-vector treated with S1PR2 inhibitor (JTE-013) F. Cell viability in T cell lines after induction of miR-126 expression. G. Cell viability in Jurkat cells transduced with empty vector or miR-126 in combination with the drug JTE-013. H. Percentage of apoptotic cells in Jurkat cell cultures expressing empty vector or vector containing miR-126 I. Percentage of cells in phases of the cell cycle in Jurkat cell cultures expressing empty vector or vector containing miR-126. J. Expression of miR-145 in normal B cell subsets, CD3+ T cells and Stroma cells profiled using the qRT-PCR based ABI platform. K. Expression of miR-145 in PTCL subsets profiled using nCounter platform. L. miR-145 expression in Jurkat cells after ectopic expression of miR-145 or vector control. M. Cell viability in Jurkat cells transduced with vector control or miR-145.
Figure S4 from The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
Authors: Arai Hiroyuki , Elliott Andrew , Xiu Joanne , Wang Jingyuan , Battaglin Francesca , Kawanishi Natsuko , Soni Shivani , Zhang Wu , Millstein Joshua , Sohal Davendra , Goldberg Richard M. , Hall Michael J. , Scott Aaron J. , Khushman Moh'd , Hwang Jimmy J. , Lou Emil , Weinberg Benjamin A. , Marshall John L. , Lockhart Albert C. , Stafford Phillip , Zhang Jian , Moretto Roberto , Cremolini Chiara , Korn W. Michael , Lenz Heinz-Josef
Published: April 2023

The frequency of DDR pathways alteration by BRAF status
Figure S2 from The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
Authors: Arai Hiroyuki , Elliott Andrew , Xiu Joanne , Wang Jingyuan , Battaglin Francesca , Kawanishi Natsuko , Soni Shivani , Zhang Wu , Millstein Joshua , Sohal Davendra , Goldberg Richard M. , Hall Michael J. , Scott Aaron J. , Khushman Moh'd , Hwang Jimmy J. , Lou Emil , Weinberg Benjamin A. , Marshall John L. , Lockhart Albert C. , Stafford Phillip , Zhang Jian , Moretto Roberto , Cremolini Chiara , Korn W. Michael , Lenz Heinz-Josef
Published: April 2023

The frequency of DDR pathways alteration by sidedness
Supplementary Table S4 from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial
Authors: Subbiah Vivek , Gainor Justin F. , Oxnard Geoffrey R. , Tan Daniel S.W. , Owen Dwight H. , Cho Byoung Chul , Loong Herbert H. , McCoach Caroline E. , Weiss Jared , Kim Yu Jung , Bazhenova Lyudmila , Park Keunchil , Daga Haruko , Besse Benjamin , Gautschi Oliver , Rolfo Christian , Zhu Edward Y. , Kherani Jennifer F. , Huang Xin , Kang Suhyun , Drilon Alexander
Published: April 2023

TEAEs and TRAEs of any grade
Supplementary Table S3 from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial
Authors: Subbiah Vivek , Gainor Justin F. , Oxnard Geoffrey R. , Tan Daniel S.W. , Owen Dwight H. , Cho Byoung Chul , Loong Herbert H. , McCoach Caroline E. , Weiss Jared , Kim Yu Jung , Bazhenova Lyudmila , Park Keunchil , Daga Haruko , Besse Benjamin , Gautschi Oliver , Rolfo Christian , Zhu Edward Y. , Kherani Jennifer F. , Huang Xin , Kang Suhyun , Drilon Alexander
Published: April 2023

Tumor response of patients with RET fusion-positive NSCLC & non-measurable intracranial disease
Supplementary Table S1 from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial
Authors: Subbiah Vivek , Gainor Justin F. , Oxnard Geoffrey R. , Tan Daniel S.W. , Owen Dwight H. , Cho Byoung Chul , Loong Herbert H. , McCoach Caroline E. , Weiss Jared , Kim Yu Jung , Bazhenova Lyudmila , Park Keunchil , Daga Haruko , Besse Benjamin , Gautschi Oliver , Rolfo Christian , Zhu Edward Y. , Kherani Jennifer F. , Huang Xin , Kang Suhyun , Drilon Alexander
Published: April 2023

Summary of Treatment and Study Disposition
Table S5 from Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma
Authors: Ewing Ailith , Meynert Alison , Churchman Michael , Grimes Graeme R. , Hollis Robert L. , Herrington C. Simon , Rye Tzyvia , Bartos Clare , Croy Ian , Ferguson Michelle , Lennie Mairi , McGoldrick Trevor , McPhail Neil , Siddiqui Nadeem , Dowson Suzanne , Glasspool Rosalind , Mackean Melanie , Nussey Fiona , McDade Brian , Ennis Darren , McMahon Lynn , Matakidou Athena , Dougherty Brian , March Ruth , Barrett J. Carl , McNeish Iain A. , Biankin Andrew V. , Roxburgh Patricia , Gourley Charlie , Semple Colin A.
Published: April 2023

Genes in KEGG HR pathway
Table S2 from Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma
Authors: Ewing Ailith , Meynert Alison , Churchman Michael , Grimes Graeme R. , Hollis Robert L. , Herrington C. Simon , Rye Tzyvia , Bartos Clare , Croy Ian , Ferguson Michelle , Lennie Mairi , McGoldrick Trevor , McPhail Neil , Siddiqui Nadeem , Dowson Suzanne , Glasspool Rosalind , Mackean Melanie , Nussey Fiona , McDade Brian , Ennis Darren , McMahon Lynn , Matakidou Athena , Dougherty Brian , March Ruth , Barrett J. Carl , McNeish Iain A. , Biankin Andrew V. , Roxburgh Patricia , Gourley Charlie , Semple Colin A.
Published: April 2023

SVs at BRCA1/2
Supplementary Tables 1-5 from Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
Authors: Xiao Lin , Somers Klaartje , Murray Jayne , Pandher Ruby , Karsa Mawar , Ronca Emma , Bongers Angelika , Terry Rachael , Ehteda Anahid , Gamble Laura D. , Issaeva Natalia , Leonova Katerina I. , O'Connor Aisling , Mayoh Chelsea , Venkat Pooja , Quek Hazel , Brand Jennifer , Kusuma Frances K. , Pettitt Jessica A. , Mosmann Erin , Kearns Adam , Eden Georgina , Alfred Stephanie , Allan Sophie , Zhai Lei , Kamili Alvin , Gifford Andrew J. , Carter Daniel R. , Henderson Michelle J. , Fletcher Jamie I. , Marshall Glenn , Johnstone Ricky W. , Cesare Anthony J. , Ziegler David S. , Gudkov Andrei V. , Gurova Katerina V. , Norris Murray D. , Haber Michelle
Published: April 2023

Supplementary Tables S1-S5
Supplementary Table 2 from Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody–Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide
Authors: de Bono Johann S. , Fleming Mark T. , Wang Judy S. , Cathomas Richard , Miralles Manuel Selvi , Bothos John , Hinrichs Mary Jane , Zhang Qu , He Peng , Williams Marna , Rosenbaum Anton I. , Liang Meina , Vashisht Kapil , Cho Song , Martinez Pablo , Petrylak Daniel P.
Published: April 2023

Summary of mean (%CV) PK parameters of Total ADC and Active ADC after a single IV infusion of MEDI3726
Supplementary Figure Legends from Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
Authors: Xiao Lin , Somers Klaartje , Murray Jayne , Pandher Ruby , Karsa Mawar , Ronca Emma , Bongers Angelika , Terry Rachael , Ehteda Anahid , Gamble Laura D. , Issaeva Natalia , Leonova Katerina I. , O'Connor Aisling , Mayoh Chelsea , Venkat Pooja , Quek Hazel , Brand Jennifer , Kusuma Frances K. , Pettitt Jessica A. , Mosmann Erin , Kearns Adam , Eden Georgina , Alfred Stephanie , Allan Sophie , Zhai Lei , Kamili Alvin , Gifford Andrew J. , Carter Daniel R. , Henderson Michelle J. , Fletcher Jamie I. , Marshall Glenn , Johnstone Ricky W. , Cesare Anthony J. , Ziegler David S. , Gudkov Andrei V. , Gurova Katerina V. , Norris Murray D. , Haber Michelle
Published: April 2023

Supplementary Figure Legends S1-S16
Supplementary Figure 1 from Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody–Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide
Authors: de Bono Johann S. , Fleming Mark T. , Wang Judy S. , Cathomas Richard , Miralles Manuel Selvi , Bothos John , Hinrichs Mary Jane , Zhang Qu , He Peng , Williams Marna , Rosenbaum Anton I. , Liang Meina , Vashisht Kapil , Cho Song , Martinez Pablo , Petrylak Daniel P.
Published: April 2023

CTC while on treatment (patients with at least one CTC measurement >50)
Table S8 from Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies
Authors: Tayari Mina M. , Santos Helena G. Dos , Kwon Deukwoo , Bradley Terrence J. , Thomassen Amber , Chen Charles , Dinh Yvonne , Perez Aymee , Zelent Arthur , Morey Lluis , Cimmino Luisa , Shiekhattar Ramin , Swords Ronan T. , Watts Justin M.
Published: April 2023

Table S8
Table S7 from Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies
Authors: Tayari Mina M. , Santos Helena G. Dos , Kwon Deukwoo , Bradley Terrence J. , Thomassen Amber , Chen Charles , Dinh Yvonne , Perez Aymee , Zelent Arthur , Morey Lluis , Cimmino Luisa , Shiekhattar Ramin , Swords Ronan T. , Watts Justin M.
Published: April 2023

Table S7
Figure S3 from Quantification of Translocation-Specific ctDNA Provides an Integrating Parameter for Early Assessment of Treatment Response and Risk Stratification in Ewing Sarcoma
Authors: Krumbholz Manuela , Eiblwieser Johanna , Ranft Andreas , Zierk Jakob , Schmidkonz Christian , Stütz Adrian M , Peneder Peter , Tomazou Eleni M. , Agaimy Abbas , Bäuerle Tobias , Hartmann Wolfgang , Dirksen Uta , Metzler Markus
Published: April 2023

Event-free survival (EFS) and overall survival (OS) by quantified pretreatment ctDNA levels for patients with localized or metastatic disease.
Figure S1 from Quantification of Translocation-Specific ctDNA Provides an Integrating Parameter for Early Assessment of Treatment Response and Risk Stratification in Ewing Sarcoma
Authors: Krumbholz Manuela , Eiblwieser Johanna , Ranft Andreas , Zierk Jakob , Schmidkonz Christian , Stütz Adrian M , Peneder Peter , Tomazou Eleni M. , Agaimy Abbas , Bäuerle Tobias , Hartmann Wolfgang , Dirksen Uta , Metzler Markus
Published: April 2023

Composition of the study groups with a good histological response and poor histological response with regard to tumor volume, presence of metastases, and osseous localization.
Supplementary Data Figures and Tables from Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)
Authors: Roussos Torres Evanthia T. , Rafie Christine , Wang Chenguang , Lim David , Brufsky Adam , LoRusso Patricia , Eder Joseph Paul , Chung Vincent , Downs Melinda , Geare Molly , Piekarz Richard , Streicher Howard , Anforth Leslie , Rudek Michelle A. , Zhu Qingfeng , Besharati Sepideh , Cimino-Mathews Ashley , Anders Robert A. , Stearns Vered , Jaffee Elizabeth M. , Connolly Roisin M.
Published: April 2023

All supplementary figures and tables
Figure S2 from Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies
Authors: Tayari Mina M. , Santos Helena G. Dos , Kwon Deukwoo , Bradley Terrence J. , Thomassen Amber , Chen Charles , Dinh Yvonne , Perez Aymee , Zelent Arthur , Morey Lluis , Cimmino Luisa , Shiekhattar Ramin , Swords Ronan T. , Watts Justin M.
Published: April 2023

Supplementary Figure S2. Differences in gene expression in patient samples between responders and non-responders.
Figure S1 from Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies
Authors: Tayari Mina M. , Santos Helena G. Dos , Kwon Deukwoo , Bradley Terrence J. , Thomassen Amber , Chen Charles , Dinh Yvonne , Perez Aymee , Zelent Arthur , Morey Lluis , Cimmino Luisa , Shiekhattar Ramin , Swords Ronan T. , Watts Justin M.
Published: April 2023

Supplementary Figure S1. Treatment-related adverse events (TRAEs) in patients treated with ATRA-TCP.
Supplementary Data from Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors
Authors: He Xuexin , Ji Jiali , Dai Xiaolan , Qdaisat Aiham Z. , Esteva Francisco J. , Hortobagyi Gabriel N. , Yeung Sai-Ching J.
Published: April 2023

Supplementary Data from Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors
Supplementary Figure 6 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
Authors: Ali Aesha I. , Wang Minyu , von Scheidt Bianca , Dominguez Pilar M. , Harrison Aaron J. , Tantalo Daniela G.M. , Kang Jian , Oliver Amanda J. , Chan Jack D. , Du Xin , Bai Yuchen , Lee Belinda , Johnstone Ricky W. , Darcy Phillip K. , Kershaw Michael H. , Slaney Clare Y.
Published: April 2023

Supplementary Figure 6. The infiltration of CD8+ cells to the Her2+ non-tumor regions.
Table S3 from Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors
Authors: Chakraborty Goutam , Patail Nabeela Khan , Hirani Rahim , Nandakumar Subhiksha , Mazzu Ying Z. , Yoshikawa Yuki , Atiq Mohammad , Jehane Lina E. , Stopsack Konrad H. , Lee Gwo-Shu Mary , Abida Wassim , Morris Michael J. , Mucci Lorelei A. , Danila Daniel , Kantoff Philip W.
Published: April 2023

Table S3
Figure S6 from Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors
Authors: Chakraborty Goutam , Patail Nabeela Khan , Hirani Rahim , Nandakumar Subhiksha , Mazzu Ying Z. , Yoshikawa Yuki , Atiq Mohammad , Jehane Lina E. , Stopsack Konrad H. , Lee Gwo-Shu Mary , Abida Wassim , Morris Michael J. , Mucci Lorelei A. , Danila Daniel , Kantoff Philip W.
Published: April 2023

Figure S6
Supplementary Data from Pharmacologic Targeting of Mcl-1 Induces Mitochondrial Dysfunction and Apoptosis in B-Cell Lymphoma Cells in a TP53- and BAX-Dependent Manner
Authors: Liu Tingting , Lam Vi , Thieme Elana , Sun Duanchen , Wang Xiaoguang , Xu Fei , Wang Lili , Danilova Olga V. , Xia Zheng , Tyner Jeffrey W. , Kurtz Stephen E. , Danilov Alexey V.
Published: April 2023

Methods
Figure S2 from Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors
Authors: Chakraborty Goutam , Patail Nabeela Khan , Hirani Rahim , Nandakumar Subhiksha , Mazzu Ying Z. , Yoshikawa Yuki , Atiq Mohammad , Jehane Lina E. , Stopsack Konrad H. , Lee Gwo-Shu Mary , Abida Wassim , Morris Michael J. , Mucci Lorelei A. , Danila Daniel , Kantoff Philip W.
Published: April 2023

Figure S2
Supplementary Data from Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study
Authors: Byers Lauren Averett , Bentsion Dmitry , Gans Steven , Penkov Konstantin , Son ChoonHee , Sibille Anne , Owonikoko Taofeek K. , Groen Harry J.M. , Gay Carl M. , Fujimoto Junya , de Groot Patricia , Dunbar Martin , Kang Kingston , He Lei , Sehgal Vasudha , Glasgow Jaimee , Bach Bruce Allen , Ellis Peter M.
Published: April 2023

Supplement
Supplementary Figure S4 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
Authors: Kerbauy Lucila N. , Marin Nancy D. , Kaplan Mecit , Banerjee Pinaki P. , Berrien-Elliott Melissa M. , Becker-Hapak Michelle , Basar Rafet , Foster Mark , Garcia Melo Luciana , Neal Carly C. , McClain Ethan , Daher May , Nunez Cortes Ana Karen , Desai Sweta , Inng Lim Francesca Wei , Mendt Mayela Carolina , Schappe Timothy , Li Li , Shaim Hila , Shanley Mayra , Ensley Emily L. , Uprety Nadima , Wong Pamela , Liu Enli , Ang Sonny O. , Cai Rong , Nandivada Vandana , Mohanty Vakul , Miao Qi , Shen Yifei , Baran Natalia , Fowlkes Natalie W. , Chen Ken , Muniz-Feliciano Luis , Champlin Richard E. , Nieto Yago L. , Koch Joachim , Treder Martin , Fischer Wolfgang , Okamoto Oswaldo Keith , Shpall Elizabeth J. , Fehniger Todd A. , Rezvani Katayoun
Published: April 2023

Supplementary Fig. S4. AFM13 binding enhances cytotoxicity against CD30+ but not CD30- lymphoma targets.
Supplementary Figure S10 from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
Authors: Chu Carissa E. , Sjöström Martin , Egusa Emily A. , Gibb Ewan A. , Badura Michelle L. , Zhu Jun , Koshkin Vadim S. , Stohr Bradley A. , Meng Maxwell V. , Pruthi Raj S. , Friedlander Terence W. , Lotan Yair , Black Peter C. , Porten Sima P. , Feng Felix Y. , Chou Jonathan
Published: April 2023

(A) NECTIN4 surface protein expression in TCCSUP Control and TCCSUP NECTIN4 OE cells. (B) EV dose-response clonogenic assay in TCCSUP Control and TCCSUP NECTIN4 OE cells.
Table S4 from Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma
Authors: Tong Kit I. , Yoon Sharon , Isaev Keren , Bakhtiari Mehran , Lackraj Tracy , He Michael Y. , Joynt Jesse , Silva Anjali , Xu Maria C. , Privé Gilbert G. , He Housheng Hansen , Tiedemann Rodger E. , Chavez Elizabeth A. , Chong Lauren C. , Boyle Merrill , Scott David W. , Steidl Christian , Kridel Robert
Published: April 2023

gProfiler results for pathways enriched by significantly differentially expressed genes with increased acetylation and gene expression.
Supplementary Data 3 from Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease
Authors: DeCensi Andrea , Puntoni Matteo , Johansson Harriet , Guerrieri-Gonzaga Aliana , Caviglia Silvia , Avino Franca , Cortesi Laura , Ponti Antonio , Pacquola Maria Grazia , Falcini Fabio , Gulisano Marcella , Digennaro Maria , Cariello Anna , Cagossi Katia , Pinotti Graziella , Lazzeroni Matteo , Serrano Davide , Briata Irene Maria , Buttiron Webber Tania , Boni Luca , Bonanni Bernardo
Published: April 2023

CONSORT Checklist
Supplementary section from Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer
Authors: Sharma Priyanka , Abramson Vandana G. , O'Dea Anne , Nye Lauren , Mayer Ingrid , Pathak Harsh B. , Hoffmann Marc , Stecklein Shane R. , Elia Manana , Lewis Sharon , Scott Jecinta , De Jong Jilliann A. , Wang Yen Y. , Yoder Rachel , Schwensen Kelsey , Finke Karissa , Heldstab Jaimie , LaFaver Stephanie , Williamson Stephen K. , Phadnis Milind A. , Reed Gregory A. , Kimler Bruce F. , Khan Qamar J. , Godwin Andrew K.
Published: April 2023

Supplementary text
Supplementary Figure 7 from PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions
Authors: Nimmakayala Rama Krishna , Rauth Sanchita , Chirravuri Venkata Ramakanth , Marimuthu Saravanakumar , Nallasamy Palanisamy , Vengoji Raghupathy , Lele Subodh M. , Rachagani Satyanarayana , Mallya Kavita , Malafa Mokenge P. , Ponnusamy Moorthy P. , Batra Surinder K.
Published: April 2023

Gnas induction elevates stemness feature in during IPMN development.
Supplementary Figure 6 from PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions
Authors: Nimmakayala Rama Krishna , Rauth Sanchita , Chirravuri Venkata Ramakanth , Marimuthu Saravanakumar , Nallasamy Palanisamy , Vengoji Raghupathy , Lele Subodh M. , Rachagani Satyanarayana , Mallya Kavita , Malafa Mokenge P. , Ponnusamy Moorthy P. , Batra Surinder K.
Published: April 2023

H&E staining showing IPMN regions in KC Smad4- mice pancreas.
Supplementary Figure 15 from PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions
Authors: Nimmakayala Rama Krishna , Rauth Sanchita , Chirravuri Venkata Ramakanth , Marimuthu Saravanakumar , Nallasamy Palanisamy , Vengoji Raghupathy , Lele Subodh M. , Rachagani Satyanarayana , Mallya Kavita , Malafa Mokenge P. , Ponnusamy Moorthy P. , Batra Surinder K.
Published: April 2023

SR18292, an inhibitor of PGC1α reduces stemness in IPMN